The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors: Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease
Open accessAbstract
Glycogen synthase kinase 3 beta (GSK-3beta) has a central role in Alzheimer's disease (AD). Selective inhibitors which avoid tau hyperphosphorylation may represent an effective therapeutical approach to the AD pharmacotherapy and other neurodegenerative disorders. Here, we describe the synthesis, biological evaluation, and SAR of the small heterocyclic thiadiazolidinones (TDZD) as the first non-ATP competitive inhibitor of GSK-3beta. Their synthesis is based on the reactivity of sulfenyl chlorides. In GSK-3beta assays, TDZD derivatives showed IC(50) values in the micromolar range, whereas in other protein kinases assays they were devoid of any inhibitory activity. SAR studies allowed the identification of the key structural features. Finally, a possible enzymatic binding mode is proposed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frame, S., Cohen, P., & Biondi, R. M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00253-2 · Cited by 701
Crystal Structure of Glycogen Synthase Kinase 3β
Dajani, R., Fraser, E., Roe, S. M., Young, N., Good, V., Dale, T. C., & Pearl, L. H. (2001) · Cell · doi:10.1016/s0092-8674(01)00374-9 · Cited by 674
Belmont, L. D., & Mitchison, T. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81037-5 · Cited by 663
Meijer, L., Thunnissen, A.-M., White, A., Garnier, M., Nikolic, M., Tsai, L.-H., Walter, J., Cleverley, K., Salinas, P., Wu, Y.-Z., et al. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00063-6 · Cited by 454
Presenilin 1 associates with glycogen synthase kinase-3β and its substrate tau
Takashima, A., Murayama, M., Murayama, O., Kohno, T., Honda, T., Yasutake, K., Nihonmatsu, N., Mercken, M., Yamaguchi, H., Sugihara, S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9637 · Cited by 409
Structure of GSK3beta reveals a primed phosphorylation mechanism.
ter Haar, E., Coll, J. T., Austen, D. A., Hsiao, H.-M., Swenson, L. L., & Jain, J. (2001) · Nature Structural Biology · doi:10.1038/89624 · Cited by 407
Paullones are potent inhibitors of glycogen synthase kinase‐3β and cyclin‐dependent kinase 5/p25
Leost, M., Schultz, C., Link, A., Wu, Y., Biernat, J., Mandelkow, E., Bibb, J. A., Snyder, G. L., Greengard, P., Zaharevitz, D. W., et al. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01673.x · Cited by 376
Spittaels, K., Van den Haute, C., Van Dorpe, J., Geerts, H., Mercken, M., Bruynseels, K., Lasrado, R., Vandezande, K., Laenen, I., Boon, T., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006219200 · Cited by 316
Harwood, A. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00412-3 · Cited by 291
Walsh, M. P., Valentine, K. A., Ngai, P. K., Carruthers, C. A., & Hollenberg, M. D. (1984) · Biochemical Journal · doi:10.1042/bj2240117 · Cited by 201
Flaherty, D. B., Soria, J., Tomasiewicz, H. G., & Wood, J. G. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20001101)62:3<463::aid-jnr16>3.0.co;2-7 · Cited by 178
Hers, I., Tavaré, J. M., & Denton, R. M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01389-7 · Cited by 144
GSK-3: New Thoughts on an Old Enzyme
Ferkey, D. M., & Kimelman, D. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9816 · Cited by 112
N-Benzylpiperidine derivatives of 1,2,4-thiadiazolidinone as new acetylcholinesterase inhibitors
Martı́nez, A., Fernandez, E., Castro, A., Conde, S., Rodrı́guez-Franco, M. I., Baños, J.-E., & Badı́a, A. (2000) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(00)01166-1 · Cited by 79
Self-citationAnderton, B. H., Dayanandan, R., Killick, R., & Lovestone, S. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01640-8 · Cited by 60
Use of peptide substrates for affinity purification of protein-serine kinases
Woodgett, J. R. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90423-5 · Cited by 38
Tau protein as a therapeutic target in Alzheimer’s disease and other neurodegenerative disorders
Larner, A. J. (1999) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.9.10.1359 · Cited by 11
Research works printed but not linked: 19
- Brion J. P., 2001, Neurofibrillary Tangles and Tau Phosphorylation. Biochem. Soc. Symp.
- Alonso A., 2001, Proc. Natl. Acad. Sci. U.S.A., 98, 6928
- Anderton B. H., 2001, M. Sites of Phosphorylation in Tau and Factors Affecting Their Regulation. Biochem. Soc. Symp.
- Castro A., 2000, Expert Opin. Ther. Pat., 10, 1527
- Imahori K., 1997, J. Biochem., 121, 188
- Applin A. E., 1997, Neuroreport, 8, 643
- Lau K. F., 1999, J. Pept. Res., 54, 91
- Lucas J. J., 2001, EMBO J., 20, 39
- Muñoz-Montaño J. R., 1997, FEBS Lett., 411, 188
- Takahashi M., 1999, J. Neurochem., 73, 2083
- Smith D. G., 2001, Bioorg. Med. Chem. Lett., 11, 639
- Leclercq S., 2001, J. Biol. Chem., 276, 260
- Martinez A., 2000, May
- Ottman G., 1966, N-Aryl and N-Alkyl-S-Chloroisothiocarbamoyl Chlorides with Isocyantes. Synthesis of 1,2,4-Thiadiazolidine-3,5-diones. Angew. Chem., Int. Ed. Engl., 5, 673
- Martinez A., 1997, Bioorg. Med. Chem., 5, 1283, 10.1016/S0968-0896(97)00077-1 · doi:10.1016/s0968-0896(97)00077-1
- Martinez A., 1999, Arch. Pharm. Pharm. Med. Chem., 332, 194
- Kaugars G., 1992, J. Org. Chem., 57, 1676, 10.1021/jo00032a014 · doi:10.1021/jo00032a014
- Garcia-Echevarria C., 2000, Med. Res. Rev., 20, 57
- Alcazar A., 1988, Neurochem. Res., 13, 836, 10.1007/BF00970750 · doi:10.1007/bf00970750
Cited by
GSK-3: tricks of the trade for a multi-tasking kinase
Doble, B. W., & Woodgett, J. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00384 · Cited by 2,084
Tau-targeting therapies for Alzheimer disease
Congdon, E. E., & Sigurdsson, E. M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0013-z · Cited by 1,113
Kinase drug discovery 20 years after imatinib: progress and future directions
Cohen, P., Cross, D., & Jänne, P. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00195-4 · Cited by 1,024
Beaulieu, J.-M., Sotnikova, T. D., Yao, W.-D., Kockeritz, L., Woodgett, J. R., Gainetdinov, R. R., & Caron, M. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307921101 · Cited by 793
Tau protein kinases: Involvement in Alzheimer's disease
Martin, L., Latypova, X., Wilson, C. M., Magnaudeix, A., Perrin, M.-L., Yardin, C., & Terro, F. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2012.06.003 · Cited by 631
Metadata
- Authors
- Martinez, A., Alonso, M., Castro, A., Pérez, C., & Moreno, F. J.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2002-02-13
- Volume
- 45
- Issue
- 6
- Pages
- 1292-1299
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W1995377960
- Cited by
- 455
- References
- 17
- FWCI
- 10.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.